Similar Stocks · Benchmarked Analysis · Peer Group

Peer Group Analysis

Configuration
Company Price d* Change d* Volume, Avg. k, d* Market Cap. d* Revenue Profit Net Earnings Free Cash Flow Dividend Yield P/E EPS Gross Margin % Net Margin % ROE % ROA % Quick Ratio % Shares Outstanding d*
Drug Manufacturers—General Average - - - - - - 151,954.08 9,237.30 529.85 21,448.11 881.11 0.01 3.2633 0.37 0.6439 0.0338 0.00 0.00 0.9030 - -
Maximum - - - - - - 789,394.00 21,382.00 4,762.00 153,378.00 3,847.00 0.04 76.3636 2.71 0.8250 0.3012 0.05 0.18 3.5022 - -
Minimum - - - - - - 0.00 910.00 -11,911.00 -27,870.00 -2,626.00 0.00 -335.6404 -5.89 0.0683 -1.0039 -0.12 -0.72 0.0000 - -
Amgen Inc. AMGN 325.28 3.37 1.05% 1,806 vs. 1,842 174,848.00 7,396.00 -113.00 459.00 -27,870.00 -0.2100 -335.6404 0.0080 0.5673 -0.0153 -0.0225 -0.0012 0.8362 537.00
Eli Lilly and Company LLY 831.54 34.09 4.27% 5,749 vs. 3,157 789,394.00 8,768.00 2,242.00 179.00 12,553.00 2.4900 76.3636 0.0017 0.8250 0.2558 0.1751 0.0351 0.6775 949.00
Merck & Co., Inc. MRK 102.92 1.75 1.73% 6,160 vs. 9,180 260,882.00 15,809.00 4,762.00 2,229.00 56,697.00 1.8800 17.4190 0.0059 0.7511 0.3012 0.1180 0.0450 0.7284 2,534.00
AbbVie Inc. ABBV 199.50 -1.01 -0.50% 4,496 vs. 4,680 352,384.00 12,310.00 1,369.00 3,847.00 -2,384.00 0.7700 58.3938 0.0087 0.6684 0.1112 0.1710 0.0092 0.7229 1,766.00
Bristol-Myers Squibb Company BMY 54.14 -0.57 -1.04% 9,215 vs. 10,712 109,805.00 11,865.00 -11,911.00 2,550.00 15,640.00 -5.8900 -2.2500 0.0113 0.7529 -1.0039 -0.7223 -0.1203 0.9190 2,028.00
*d means the data is delayed 15 minutes at minimum.
More Due Diligence
Compare Fundamentals
Leverage our visualization and data tables to compare over 25 years of financial data for AAPL and its peers.
Watchlist
Keep an eye one one or all of the stocks by building a new watchlist.
Intrinsic Values
Utilize our versatile Gordan Growth Model for LLY.DE and its peers to uncover potential buy and sell opportunities.